Section one: Contracting authority
one.1) Name and addresses
NHS England
Leeds
Contact
Anna Salt
Country
United Kingdom
Region code
UK - United Kingdom
Justification for not providing organisation identifier
Not on any register
Internet address(es)
Main address
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
DNA Repair Disorders Service
two.1.2) Main CPV code
- 85000000 - Health and social work services
two.1.3) Type of contract
Services
two.1.4) Short description
DNA nucleotide excision repair (DNA) disorders include xeroderma pigmentosa (XP), Cockayne syndrome (CS) and trichothiodystrophy (TTD). Xeroderma Pigmentosa (XP) service was commissioned as a HSS in 2010, the service specification was updated in 2018 to include the CS and TTD. These are rare inherited multi-organ disorders and patients have specific, complex and specialist needs. Although the underlying diseases are not curable, there is potential to significantly improve health and quality of life through a comprehensive, expert patient focused service. Many individuals with CS/TTD require photoprotection, have reduced mobility or are on supplemental feeds.
The conditions are complex to diagnose and treat, and require input from: dermatology, dermatological surgery, paediatric neurology, adult neurology, ophthalmology, neuropsychology, clinical genetics, paediatric dentistry, psychology, dietetics, endocrinology, optometry, medical photography, audiology and palliative care.
two.1.6) Information about lots
This contract is divided into lots: No
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £7,186,475
two.2) Description
two.2.3) Place of performance
NUTS codes
- UKI - London
two.2.4) Description of the procurement
DNA nucleotide excision repair (DNA) disorders include xeroderma pigmentosa (XP), Cockayne syndrome (CS) and trichothiodystrophy (TTD). Xeroderma Pigmentosa (XP) service was commissioned as a HSS in 2010, the service specification was updated in 2018 to include the CS and TTD. These are rare inherited multi-organ disorders and patients have specific, complex and specialist needs. Although the underlying diseases are not curable, there is potential to significantly improve health and quality of life through a comprehensive, expert patient focused service. Many individuals with CS/TTD require photoprotection, have reduced mobility or are on supplemental feeds. These circumstances can impact their ability to maintain optimal vitamin D levels. Therefore, regular vitamin D monitoring is important. are genetic conditions that are complex to diagnose and treat, and require input from: dermatology, dermatological surgery, paediatric neurology, adult neurology, ophthalmology, neuropsychology, clinical genetics, paediatric dentistry, psychology, dietetics, endocrinology, optometry, medical photography, audiology and palliative care.
An award has been made following direct award process A.
The service started on 1st April 2024 for a period of 3 years with an option to extend for a further 2 years.
The lifetime value of the contract is £7,186,475.00.
two.2.5) Award criteria
Cost criterion - Name: No realistic alternative provider / Weighting: 100
two.2.11) Information about options
Options: Yes
Description of options
There is an option to extend the contract for an additional 2 years.
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Award of a contract without prior publication of a call for competition in the cases listed below
- The procurement falls outside the scope of application of the regulations
Explanation:
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
Section five. Award of contract
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
5 September 2024
five.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Guy's and St Thomas' NHS Foundation Trust
London
Country
United Kingdom
NUTS code
- UKI - London
Justification for not providing organisation identifier
Not on any register
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Total value of the contract/lot: £7,186,475
Section six. Complementary information
six.3) Additional information
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.
Decision makers: National Commissioning Group (NCG)
Tuesday 27th February 2024 AND Clinical Executive Group (CEG)
Tuesday 12th March 2024
Conflicts of Interest identified among NCG and CEG: None
six.4) Procedures for review
six.4.1) Review body
Arden & Gem CSU
St John's House, East Street
Leicester
LE1 6NB
Country
United Kingdom